Maravai LifeSciences (MRVI)
(Real Time Quote from BATS)
$10.95 USD
+0.25 (2.34%)
Updated May 15, 2024 10:30 AM ET
3-Hold of 5 3
C Value F Growth D Momentum D VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Bottom 42% (145 out of 250)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.63 | 1.69 | 9.99 |
Current Quarter Estimate | 0.00 | 5.88 | 57.00 |
Year Ago Quarter Estimate | 0.00 | 4.88 | 52.54 |
Next Quarter Estimate | 0.00 | 7.06 | 61.00 |
Next Year Estimate | 0.05 | 39.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -133.33 | 17.50 | 15.67 |
Next Year | 600.00 | 23.90 | 9.31 |
Last 5 Years | NA | 3.90 | 8.10 |
Next 5 Years | NA | 11.00 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -13.85 |
Price/Book (MRQ) | 3.46 | 1.97 |
Price/Cash Flow (MRFY) | 112.99 | 11.32 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -47.81% | -4.70% |
Return on Equity (TTM) | -4.28% | 3.44% |
Debt to Equity (MRQ) | 0.71 | 27.76 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.